Tharimmune (THAR) Stock Chart & Stock Price History $3.18 +0.16 (+5.30%) Closing price 04:00 PM EasternExtended Trading$3.16 -0.02 (-0.63%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Tharimmune Stock Price Performance The Tharimmune (THAR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 56.65%, with a year-to-date return of 56.65%. In the past month, the stock has increased 7.43%, reflecting recent market activity. As of the latest close, Tharimmune traded at $3.02 with a market cap of $17.83 million and volume of 271,294 shares. Receive THAR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tharimmune and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+9.28%1 Month Performance+7.43%3 Month Performance+80.68%Year-To-Date Performance+56.65%1 Year Performance+56.65% THAR Stock Chart for Wednesday, October, 8, 2025 THAR Chart by TradingView Tharimmune Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/08/2025$3.02$3.18+5.30%$3.40$2.97515,461 shs$18.76 million10/07/2025$3.03$3.02-0.33%$3.08$2.88271,294 shs$17.83 million10/06/2025$2.91$3.03+4.12%$3.05$2.92207,917 shs$17.88 million10/03/2025$3.05$2.91-4.59%$3.10$2.90154,758 shs$17.17 million10/02/2025$3.15$3.05-3.17%$3.17$2.98260,858 shs$18.00 million10/01/2025$2.84$3.15+10.92%$3.16$2.85323,459 shs$18.59 million09/30/2025$2.90$2.84-2.07%$2.98$2.81148,283 shs$16.76 million09/29/2025$3.02$2.90-3.97%$3.14$2.89212,814 shs$17.11 million09/26/2025$2.91$3.02+3.78%$3.08$2.91227,515 shs$17.82 million09/25/2025$2.96$2.91-1.69%$2.97$2.82264,474 shs$17.17 million Get the Latest News and Ratings for THAR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tharimmune and its competitors with MarketBeat's FREE daily newsletter. 09/24/2025$2.82$2.96+4.96%$3.33$2.621.33 million shs$17.46 million09/23/2025$2.91$2.82-3.09%$2.92$2.82268,132 shs$16.64 million09/22/2025$3.60$2.91-19.17%$3.16$2.791.02 million shs$17.17 million09/19/2025$2.66$3.60+35.34%$3.89$2.533.85 million shs$20.48 million09/18/2025$2.68$2.66-0.75%$2.79$2.58432,112 shs$15.14 million09/17/2025$2.88$2.68-6.94%$2.87$2.54741,630 shs$15.25 million09/16/2025$2.94$2.88-2.04%$2.99$2.81348,464 shs$16.39 million09/15/2025$3.14$2.94-6.37%$3.26$2.82618,432 shs$17.87 million09/12/2025$3.13$3.14+0.32%$3.46$3.13721,361 shs$17.87 million09/11/2025$3.05$3.13+2.62%$3.20$2.92794,966 shs$17.81 million09/10/2025$2.79$3.05+9.32%$3.46$2.811.81 million shs$17.35 million09/09/2025$2.96$2.79-5.74%$3.14$2.75974,980 shs$15.88 million09/08/2025$3.68$2.96-19.57%$3.63$2.941.35 million shs$16.84 million Related Companies CervoMed Stock Chart BeyondSpring Stock Chart PMV Pharmaceuticals Stock Chart Relmada Therapeutics Stock Chart Artiva Biotherapeutics Stock Chart aTyr Pharma Stock Chart ABVC BioPharma Stock Chart Clene Stock Chart Hyperion DeFi Stock Chart CEL-SCI Stock Chart Receive THAR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tharimmune and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:THAR) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored3 Major A.I. Threats That Could Upend the U.S. EconomyThe media's calling Artificial Intelligence a "revolution," but for many Americans, the real impact might actu...Goldco Precious Metals | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tharimmune, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tharimmune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
